Neurology
Younger adults with intracerebral hemorrhage have better outcomes but distinct risk profile: INTERACT3 sub-analysis
A secondary analysis of the INTERACT3 trial shows that younger adults (≤50 years) with intracerebral hemorrhage have lower mortality and disability but differ in risk factors and may benefit more from bundled care.
